A Trial to Evaluate the Efficacy and Safety of Sibeprenlimab Administered Subcutaneously in Participants With Sjögren's
Clinical trial NCT06928142 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06928142
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-23
- Primary completion
- 2027-03-13
- Enrollment
- 83
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.